Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
4basebio logo — Next generation gene therapy

4basebio

Next generation gene therapy

Founded 1997 United Kingdom Cambridge, United Kingdom 102 employees Grant Total: $299.20K Biotechnology, Health Care

General Information

Company Name 4basebio
Founded Year 1997
Location United Kingdom Cambridge, United Kingdom +1
Employees 102
Industries Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when 4basebio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About 4basebio

4basebio is a United Kingdom-based biotechnology startup focusing on next-generation gene therapy and vaccine development. With a founding year of 1997, the company has been pioneering the advancement of cell and gene therapies through its innovative technologies. Their synthetic DNA and mRNA solutions, alongside non-viral vectors for nucleic acid payload delivery, empower the development of customized and application-specific therapies and vaccines. The company's proprietary synthetic DNA technology offers a high level of customizability, rapid production, and enhanced safety profiles, effectively addressing the limitations of traditional DNA technologies. They currently offer four DNA construct types, catering to various applications such as viral and non-viral vector applications, genome editing, vaccines, therapeutics, and DNA vaccine applications. In addition to their DNA technology, 4basebio has developed Hermes™, a proprietary non-viral delivery system in the form of a nanoparticle vector. Hermes™ can be customized to target specific cells or tissues, combining the safety of lipid-based nanoparticles with the precision of a targeting system, thereby addressing the shortcomings associated with conventional viral vectors and non-targeted LNPs. The latest funding round of €299.20K came in the form of a grant investment from the la Caixa Foundation on 20 May 2020. This investment serves as a testament to the potential and direction of 4basebio, positioning them to further drive innovation and impact within the biotechnology and healthcare industries.

Taxonomy: gene therapy, synthetic DNA, mRNA technology, non-viral vectors, nucleic acid delivery systems, genome editing, vaccines, therapeutics, nanoparticle technology, DNA manufacturing, life science technology

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
20 May 2020

4basebio Alternatives & Competitors

4basebio vs
Gennao Bio
Gennao Bio United States

A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics

Series A
5 employees
Biotechnology, Health Care
Compare 4basebio vs Gennao Bio
4basebio vs
MBF Therapeutics Inc.
MBF Therapeutics Inc.

Next Generation Immunotherapeutics for Life Sciences

Grant
8 employees
Biotechnology, Health and Wellness
Compare 4basebio vs MBF Therapeutics Inc.
4basebio vs
Flash BioSolutions
Flash BioSolutions France

CDMO expert specialized in gene delivery

Debt Financing
51 employees
Biotechnology, Health Care
Compare 4basebio vs Flash BioSolutions

FAQ About 4basebio

Next generation gene therapy
4basebio was founded in 1997.
4basebio is headquartered in Cambridge, United Kingdom.
4basebio operates in the following industries: Biotechnology, Health Care.
4basebio has approximately 102 employees.
4basebio has completed 1 funding round, raising a total of $299.20K. The latest funding stage is Grant.
Top alternatives and competitors to 4basebio include Gennao Bio, MBF Therapeutics Inc., Flash BioSolutions, Avirmax, Inc., Orion Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
4basebio and Gennao Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors 4basebio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes